thrombogenics nv (THR:Euronext Brussels)
Earnings & Estimates Summary - THROMBOGENICS NV (THR)
2013 revenues at ThromboGenics NV totaled €112.8M EUR, while annual earnings equaled €0.71 per share.
Quarterly Earnings & Estimates - THROMBOGENICS NV (THR)
No earnings announcements are currently available for THROMBOGENICS NV.
Annual Earnings & Estimates - THROMBOGENICS NV (THR)
ThromboGenics NV's Annual Earnings
ThromboGenics NV reported annual 2013 earnings of €0.71 per share on 03/19/2014.
Quarterly Revenues - THROMBOGENICS NV (THR)
Annual Revenues - THROMBOGENICS NV (THR)
ThromboGenics NV's Annual Revenues
ThromboGenics NV had revenues for the full year 2013 of €112.8M EUR. This was 50.2% above the prior year's results.
|No competitor information is available for THR.|
|View Industry Companies|
|Price/Cash Flow||NM||Not Meaningful|